Business Wire

Alkion Terminals, LBC Tank Terminals and Sogestran Announce the Closing of Two Transactions for Eight Tank Terminals in France, Spain and Portugal

4.7.2017 10:56 | Business Wire

Jaa

Alkion Terminals (Alkion) and LBC Tank Terminals (LBC) today announced that on June 30th, 2017 the transaction in which Alkion acquired the 50% shareholding of LBC in LBC Sogestrol and the full ownership of 4 tank terminals in France (Bayonne, Le Havre, Marseille, Nantes), 2 tank terminals in Spain (Cartagena, Santander) and 1 tank terminal in Portugal (Lisbon) was completed.

In parallel, Alkion and Sogestran today announced that on June 30th, 2017 the transaction in which Alkion acquired the 50% shareholding of Sogestran in LBC Sogestrol was completed. Following the concomitant financial close of the transactions, Alkion will be the sole owner and operator of LBC Sogestrol, a world-class tank terminal in Le Havre, France.

Established in 2016 as a new independent tank terminal operator focusing in Western Europe, Alkion is creating a network of tank terminals that perform a primary role in the hydrocarbon downstream value chain. Following the transactions Alkion owns and operates 9 terminals in 4 countries with a tank capacity of well over 1 million cubic meter. The eight new terminal additions to the Alkion portfolio are located in key locations offering high quality service to an extensive portfolio of long term customers based on an excellent reputation. Alkion Terminals intends to invest further in improving and expanding the assets to provide its existing and new customers a world-class service.

The transactions have been financed by CACIB, SEB, HSH Nordbank, Santander, BRED and UBS Asset Management.

The parties have been advised in the process by the following parties:

  • DC Advisory (financing), Herbert Smith Freehills (legal), KPMG (tax & accounting) and Nexant (commercial) advised Alkion Terminals on the transaction.
  • Lazard (financing) and Linklaters (legal) advised LBC on the transaction.
  • Sekri Valentin Zerrouk (legal) advised Sogestran.

About Alkion Terminals

Alkion Terminals is a partnership between infrastructure investor InfraVia Capital Partners and Dutch energy expert Coloured Finches. Established in 2016 Alkion Terminals combines the tank storage industry expertise and hands-on operational expertise of Coloured Finches with the dry powder and financing expertise of InfraVia to acquire, upgrade and optimize liquid bulk terminals in Europe. Following the completion of the transactions Alkion Terminals will be owning and operating 9 terminals in the Netherlands, France, Spain and Portugal.

www.alkion.com

About LBC Tank Terminals

LBC Tank Terminals is a top-tier global independent operator of bulk liquid storage facilities for petrochemicals, petroleum products and base oil products. LBC owns and operates a global network of terminals at key locations in the United States, Europe and China, while offering loading / unloading services for all modes of transportation. Underlying the entire ethos of the company is our focus on corporate and social governance in which we strive to have a positive effect upon society and ensure that there is no such thing as a dangerous product, at least not when under our care. More information is available at www.lbctt.com

About InfraVia Capital Partners

InfraVia Capital Partners is an investment manager dedicated to the infrastructure sector. InfraVia Capital Partners manages € 1.7 billion of assets through three infrastructure funds, which are all positioned as long term investors across the infrastructure sectors in Europe.

www.infraviacapital.com

About Coloured Finches

Coloured Finches is a Dutch company established by former CEOs from the oil downstream industry. The independent group is active in the integrated downstream business and has extensive knowledge and experience in owning and operating storage terminals.

www.colouredfinches.com

Contact information

ALKION TERMINALS
Rutger VAN THIEL, +31 (0)6 83 59 06 76
CEO
rvthiel@alkion.com
or
LBC TANK TERMINALS
Christina Schosser, +32 (0)15 28 73 10
c-schosser@lbctt.com
or
SOGESTRAN
François HAAS, +33 2 32 79 26 58
Sogestran Board member
President of Sogestrol
Francois.haas@sogestran.fr
or
INFRAVIA
Vincent LEVITA, +33 (0)1 40 68 17 38
Founder & CEO
vlevita@infraviacapital.com
or
Feten BEN HARIZ, +33 (0)1 44 82 66 77
fbenhariz@agencefargo.com

Tietoja julkaisijasta

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Tilaa tiedotteet sähköpostiisi

Haluatko tietää asioista jo ennen kuin ne uutisoidaan? Kun tilaat tiedotteemme tältä julkaisijalta, saat ne sähköpostiisi yhtä aikaa suomalaisen median kanssa. Tilauksen voit halutessasi perua milloin tahansa.

Lue lisää julkaisijalta Business Wire

Major Terrorist Plot Foiled in Saudi Arabia, Ministry of Interior Announces21.7.2017 21:33Tiedote

The following is a statement from Saudi Arabia’s Ministry of Culture and Information: This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170721005575/en/ Weapons and other items found in the possession of the three terrorists are an indication of the ugliness and severity of the acts of terrorism they were planning to carry out, victimizing innocent lives and private and public property. (Photo: ME NewsWire) The Saudi Ministry of Interior has announced that a major terrorist attack was prevented by security services in the city of Saihat in the Qatif governorate. On the evening of Friday, July 14th, security services intercepted a stolen Toyota Corolla vehicle in a busy, built-up district of the city. As the stolen vehicle was surrounded by security services, three men in the ca

Janssen Receives Positive CHMP Opinion for SYMTUZA™ The First Darunavir-Based Single-Tablet Regimen for the Treatment of HIV21.7.2017 15:09Tiedote

Janssen-Cilag International NV (Janssen) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a Positive Opinion recommending marketing authorisation for SYMTUZA™ (darunavir/cobicistat/emtricitabine/tenofovir alafenamide [D/C/F/TAF]), a once-daily darunavir-based single tablet regimen (STR). If approved, it will be the only darunavir-based STR indicated for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults and adolescents aged 12 years and older with body weight of at least 40 kg, with genotypic testing guiding use. This STR combines the proven efficacy and durability of darunavir with the improved renal laboratory and bone mineral density profile of F/TAF as compared to F/TDF (tenofovir disoproxil fumarate), and will be the only treatment that could deliver the adherence advantag

Ipsen Receives Positive CHMP Opinion for Approval of Xermelo® (Telotristat Ethyl), for the Treatment of Carcinoid Syndrome Diarrhea in Patients Inadequately Controlled by Somatostatin Analogue Therapy21.7.2017 14:26Tiedote

Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY) today announced that the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMA), has adopted a positive opinion recommending the approval of Xermelo® (telotristat ethyl) 250 mg three times a day (tid) for the treatment of carcinoid syndrome diarrhea in combination with somatostatin analogue (SSA) therapy in adults inadequately controlled by SSA therapy. The CHMP positive opinion will now be reviewed by the European Commission (EC), which has the authority to approve medicines for use in the 28 countries of the European Union, as well as Norway, Liechtenstein and Iceland. David Meek, Chief Executive Officer of Ipsen, said: “The positive CHMP opinion for Xermelo ® is an important milestone towards providing innovative s

NRI Secure Launches Japan's First "Blockchain Assessment" Service21.7.2017 10:00Tiedote

NRI SecureTechnologies, Ltd. (President: Jun Odashima; hereinafter NRI Secure), a leading provider of information security solutions in Japan, has begun providing Japan’s first-ever*1 “Blockchain Assessment,” a security Assessment service designed for systems and services which use blockchain technology*2. This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170721005012/en/ Overview of the "Blockchain Assessment" Service (Graphic: Business Wire) As the blockchain technology has become more widespread, the presence of security-related vulnerabilities has also become increasingly apparent. In particular, with regard to smart contracts, *3 one of a constituent element of services using the blockchain, a cyberattack carried out on any vulnerable programs could lead to major threats or eve

Business Figures for the First Half of 2017: Sartorius Continues to Grow21.7.2017 08:00Tiedote

Sartorius (FWB:SRT), a leading international laboratory and pharmaceutical equipment supplier, continues on the growth track. In the first half of 2017, solid organic business development and two acquisitions led to a significant increase in sales revenue and earnings1. "Sartorius has continued its dynamic, profitable development," said CEO and Executive Board Chairman Dr. Joachim Kreuzburg in commenting on the company's first-half performance. "Both divisions achieved solid organic growth in an environment that was especially challenging in North America, and have made quick progress in integrating the businesses most recently acquired. In the Lab Products & Services Division, the bioanalytics unit newly created by our acquisitions has already contributed significant revenues and earnings. We see further considerable growth potential ahead for this business just as for the

Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.

Tutustu uutishuoneeseemme